Sx1 Medicated Post-operative System
Product Images NDC 70529-941

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sx1 Medicated Post-operative System (NDC 70529-941). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by It3 Medical Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lidocaine (Lido 3)

Lidocaine (Lido 3)
This is a description of a medication product called Lidocaine Hydrochloride Jelly USP, 2%. It comes in a sterile 5 mL package with a NDC number of 17478-840-05. The jelly is indicated for use as a local anesthetic and is an aqueous solution of lidocaine hydrochloride, hypromeliose, methyl and propylparaben, sodium hydroxide, and/or hydrochloric acid. The dosage information is available in the package insert, and it should be stored at 20° to 25°C (68" to 77°F) and discarded if unused. This medication is for topical use only, and not for ophthalmic use. This drug should be kept out of the reach of children. The product is made by Akom, Inc. in Lake Forest, IL 60045.*
FDA Label Image

System-1 (Sx1)

System-1 (Sx1)
This appears to be a label for a post-operative system, possibly containing medication and staple removal tools. The product's NDC (National Drug Code) is 70529-941-01.*
FDA Label Image

Tripleant (Triple 1)

Tripleant (Triple 1)
The given text is a mix of alphanumeric characters and some sentences related to drug usage instruction, warning labels, and other product details. It seems like a description of a triple antibiotic ointment used for first-aid purposes to prevent infections in minor cuts, bites or burns. The text includes active ingredients, directions for use, and warnings against allergic reactions or over-usage. The product seems to have been manufactured in Israel and is distributed by Dynarex Corporation based in Orangeburg, NY.*
FDA Label Image

Struct-1 (Structure 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.